| Dr George Kum-nji, MD | |
|
535 Commerce St, Gretna, LA 70056-7316 | |
| (724) 988-9028 | |
| (724) 252-2152 |
| Full Name | Dr George Kum-nji |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 14 Years |
| Location | 535 Commerce St, Gretna, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528389012 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | MD449718 (Pennsylvania) | Secondary |
| 208100000X | Physical Medicine & Rehabilitation | 326111 (Louisiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| National Health Rehabilitation Llc | 4284952615 | 137 |
| National Health Rehabilitation Llc | 4284952615 | 137 |
News Archive
Humans may owe their place as Earth's dominating species to their ability to share and cooperate with each other, according to a new study published in the Journal of Anthropological Research.
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today presented positive results from the LATTE-2 study at the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston. Headline results were announced in November 2015.
KAIST medical scientists identified a cellular mechanism causing inflammatory changes in regulatory T cells that can lead to severe viral hepatitis. Research on this mechanism will help further understand the nature of various inflammatory diseases and lead to the development of relevant clinical treatments.
The proprietary material was originally developed by the Manchester based company to make artificial blood vessels, used to replace diseased arteries which can lead to heart attacks and strokes, and is capable of making significant improvements in surgery for vascular disease.
In the first U.S. study of urinary arsenic in babies, Dartmouth College researchers found that formula-fed infants had higher arsenic levels than breast-fed infants, and that breast milk itself contained very low arsenic concentrations.
› Verified 7 days ago
| Entity Name | National Health Rehabilitation Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780080218 PECOS PAC ID: 4284952615 Enrollment ID: O20181010000325 |
News Archive
Humans may owe their place as Earth's dominating species to their ability to share and cooperate with each other, according to a new study published in the Journal of Anthropological Research.
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today presented positive results from the LATTE-2 study at the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston. Headline results were announced in November 2015.
KAIST medical scientists identified a cellular mechanism causing inflammatory changes in regulatory T cells that can lead to severe viral hepatitis. Research on this mechanism will help further understand the nature of various inflammatory diseases and lead to the development of relevant clinical treatments.
The proprietary material was originally developed by the Manchester based company to make artificial blood vessels, used to replace diseased arteries which can lead to heart attacks and strokes, and is capable of making significant improvements in surgery for vascular disease.
In the first U.S. study of urinary arsenic in babies, Dartmouth College researchers found that formula-fed infants had higher arsenic levels than breast-fed infants, and that breast milk itself contained very low arsenic concentrations.
› Verified 7 days ago
| Entity Name | Signify Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689158487 PECOS PAC ID: 3274895263 Enrollment ID: O20210210001575 |
News Archive
Humans may owe their place as Earth's dominating species to their ability to share and cooperate with each other, according to a new study published in the Journal of Anthropological Research.
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today presented positive results from the LATTE-2 study at the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston. Headline results were announced in November 2015.
KAIST medical scientists identified a cellular mechanism causing inflammatory changes in regulatory T cells that can lead to severe viral hepatitis. Research on this mechanism will help further understand the nature of various inflammatory diseases and lead to the development of relevant clinical treatments.
The proprietary material was originally developed by the Manchester based company to make artificial blood vessels, used to replace diseased arteries which can lead to heart attacks and strokes, and is capable of making significant improvements in surgery for vascular disease.
In the first U.S. study of urinary arsenic in babies, Dartmouth College researchers found that formula-fed infants had higher arsenic levels than breast-fed infants, and that breast milk itself contained very low arsenic concentrations.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr George Kum-nji, MD 1 Galleria Blvd Ste 1900, Metairie, LA 70001-7553 Ph: (724) 988-9028 | Dr George Kum-nji, MD 535 Commerce St, Gretna, LA 70056-7316 Ph: (724) 988-9028 |
News Archive
Humans may owe their place as Earth's dominating species to their ability to share and cooperate with each other, according to a new study published in the Journal of Anthropological Research.
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today presented positive results from the LATTE-2 study at the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston. Headline results were announced in November 2015.
KAIST medical scientists identified a cellular mechanism causing inflammatory changes in regulatory T cells that can lead to severe viral hepatitis. Research on this mechanism will help further understand the nature of various inflammatory diseases and lead to the development of relevant clinical treatments.
The proprietary material was originally developed by the Manchester based company to make artificial blood vessels, used to replace diseased arteries which can lead to heart attacks and strokes, and is capable of making significant improvements in surgery for vascular disease.
In the first U.S. study of urinary arsenic in babies, Dartmouth College researchers found that formula-fed infants had higher arsenic levels than breast-fed infants, and that breast milk itself contained very low arsenic concentrations.
› Verified 7 days ago
Dr. Gloria C. Kang, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1800 Carol Sue Ave, Suite 6, Gretna, LA 70056 Phone: 504-391-8290 Fax: 504-391-8291 |